Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Transition products commencing 1 February 2025
Offer reference number: CM/TNS/24/5713
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection
Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)
Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)
Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Additional information:
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: …@atamis.co.uk
No supplier information available.